Search results for " Infectious"

showing 10 items of 271 documents

A challenging case of chorioretinitis and skin lesions in a lung transplant recipient

2018

no

infection and infectious agentsmedicine.medical_specialtyinfectious diseaseclinical research/practicecomplication: infectioulung transplantation/pulmonologyBiopsymedicineImmunology and AllergybiopsyPharmacology (medical)Lung transplant recipientTransplantationmedicine.diagnostic_testinfection and infectious agentbusiness.industryChorioretinitisantibiotic: antifungalmedicine.diseaseinfection and infectious agents - fungalDermatologycomplication: infectiousAntibiotics antifungalInfectious disease (medical specialty)Skin lesionbusinessantibiotic: antifungal; biopsy; clinical research/practice; complication: infectious; infection and infectious agents; infection and infectious agents - fungal; infectious disease; lung transplantation/pulmonology; Immunology and Allergy; Transplantation; Pharmacology (medical)American Journal of Transplantation
researchProduct

Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications.

2020

Introduction: gd T cells have been characterized by the expression of a gd T cell receptor (TCR).When the gd TCR and the corresponding ab TCR were first discovered it was assumed that the corresponding cell types were likely to be functionally very similar. However, some 30 years later, we have realized that they are not. Unlike ab T cells, gd T cells (i) sense target antigens independent of MHC molecules; (ii) display NK-cell like innate reactivities, including killing of infected cells as well as microbes; (iii) are able to take up large particulates, including bacteria, and (iv) can act as professional antigen presenting cells. The “stress sensing” abilities of gd T cells have led to a g…

lcsh:Immunologic diseases. Allergy0301 basic medicineCell typeT cellImmunologygd T cells gd T cell receptor antigen recognition killing mechanisms infectious diseases tumor immunology.Major histocompatibility complexLigandsinfectious diseasesCommunicable DiseasesImmunotherapy Adoptiveγδ T cellsγδ T cell receptor03 medical and health sciences0302 clinical medicineAntineoplastic Agents ImmunologicalLymphocytes Tumor-InfiltratingAntigenAnti-Infective AgentsT-Lymphocyte SubsetsNeoplasmsmedicineImmunology and AllergyAnimalsHumanstumor immunologyGamma delta T cellAntigen-presenting cellSettore MED/04 - Patologia GeneralebiologyT-cell receptorReceptors Antigen T-Cell gamma-deltakilling mechanismsAcquired immune systemCell biologyantigen recognition030104 developmental biologymedicine.anatomical_structurePhenotypeEditorialbiology.proteinlcsh:RC581-607030215 immunologySignal TransductionFrontiers in immunology
researchProduct

INFECTIOUS COMPLICATIONS AFTER UMBILICAL CORD-BLOOD TRANSPLANTATION FROM UNRELATED DONORS

2016

Umbilical cord-blood (UCB) is a well-recognized alternative source of stem cells for unrelated donor hematopoietic stem cell transplantation (HSCT). As compared with other stem cell sources from adult donors, it has the advantages of immediate availability of cells, absence of risk to the donor and reduced risk of graft-versus-host disease despite donor-recipient HLA disparity. However, the use of UCB is limited by the delayed post-transplant hematologic recovery due, at least in part, to the reduced number of hematopoietic cells in the graft and the delayed or incomplete immune reconstitution. As a result, severe infectious complications continue to be a leading cause of morbidity and mort…

lcsh:RC633-647.5Umbilical Cord Blood Transplantationbusiness.industryIncidence (epidemiology)medicine.medical_treatmentReview Articlelcsh:Diseases of the blood and blood-forming organsHematologyHuman leukocyte antigenDiseaseHematopoietic stem cell transplantation: umbilical cord-blood transplantation infectious bacterial fungal viral03 medical and health sciencesHaematopoiesisfluids and secretions0302 clinical medicineInfectious DiseasesImmune system030220 oncology & carcinogenesisImmunologymedicineStem cellbusiness030215 immunologyMediterranean Journal of Hematology and Infectious Diseases
researchProduct

Providing pediatric well-care and sick visits in the COVID-19 pandemic era: the recommendations of the Italian pediatric society.

2020

AbstractPediatricians have observed a significant decrease in in-person child health visits during the COVID-19 pandemic. In the post lockdown period, the coronavirus trend remains positive in Italy but fears of a second wave have recently grown in Italy due to active hotbeds of contagion. The pandemic may negatively affect the care of pediatric patients and overall children welfare as it may present with severe signs and symptoms or it may complicate. The Italian Pediatric Society recommend to separate well visits from sick ones, to educate families and to promote hygienic strategies to provide an adequate pediatric assistance in case of a second pandemic wave.

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)COVID19Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectPneumonia ViralChild WelfareSigns and symptomsPediatricsChild healthBetacoronavirusPandemicmedicineDisease Transmission InfectiousHumansVisitChildChildrenPandemicsSocieties Medicalmedia_commonMaternal and child healthbusiness.industrySARS-CoV-2lcsh:RJ1-570COVID-19lcsh:PediatricsSettore MED/38ItalyFamily medicinePractice Guidelines as TopicCommentarybusinessCoronavirus InfectionsWelfareItalian journal of pediatrics
researchProduct

Inclusion of pregnant women in clinical trials of COVID-19 therapies: what have we learned?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Inclusion (disability rights)Pneumonia ViralMEDLINEArticlelaw.inventionBetacoronavirusRandomized controlled triallawHumansMedicinePregnancy Complications InfectiousIntensive care medicinePandemicsClinical Trials as TopicPregnancySARS-CoV-2business.industryPatient SelectionCOVID-19clinical trialmedicine.diseasedrug developmentClinical trialAnesthesiology and Pain MedicineDrug developmentFemalepregnancyCoronavirus Infectionsbusinessrandomised controlled trialBritish Journal of Anaesthesia
researchProduct

The challenge of laypeople cardio-pulmonary resuscitation training during and after COVID-19 pandemic.

2020

medicine.medical_specialty2019-20 coronavirus outbreakResuscitationCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentPneumonia ViralCPR Resuscitation COVID-10Emergency NursingEducation NonprofessionalArticleBetacoronavirusPandemicmedicineDisease Transmission InfectiousHumansCardiopulmonary resuscitationIntensive care medicinePandemicsbusiness.industrySARS-CoV-2TeachingCOVID-19Cardiopulmonary ResuscitationCardio-pulmonary resuscitationEmergencyEmergency MedicineCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsDisease transmissionCoronavirus InfectionsOut-of-Hospital Cardiac ArrestResuscitation
researchProduct

A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculos…

2016

Background: Intravesical instillation of bacille Calmette-Guérin (BCG) has been established as efficient therapy for superficial bladder carcinoma. Overall, intravesical BCG is well tolerated and results in complications of less than 5 %. However, adverse effects such as granulomatous prostatitis, pneumonitis, hepatitis, sepsis, and hypersensitivity reactions may occur. The reported rate for tuberculous orchitis after BCG intravesical therapy is 0.4 %. Findings: We report a case of monolateral tuberculous orchitis occurring one month after the second course of intravescical instillation of bacille Calmette-Guérin in a patient with proven superficial bladder carcinoma and latent tuberculosis…

medicine.medical_specialtyCancer ResearchComplicationsSettore MED/17 - Malattie InfettiveEpidemiologyBladder030232 urology & nephrologyUrologyShort ReportInfectious DiseaseGastroenterologySepsis03 medical and health sciences0302 clinical medicineInternal medicinemedicineGranulomatous prostatitisBladder; Calmette; Complications; Guérin; Intravesical; Infectious Diseases; Oncology; Epidemiology; Cancer ResearchPneumonitisHepatitisLatent tuberculosisbusiness.industryIntravesicalIsoniazidmedicine.diseaseInfectious DiseasesOncology030220 oncology & carcinogenesisOrchitisSuperficial Bladder CarcinomabusinessComplicationGuérinmedicine.drugCalmetteInfectious Agents and Cancer
researchProduct

Clinical management of drug-drug interactions in HCV therapy: Challenges and solutions.

2013

Contains fulltext : 118153.pdf (Publisher’s version ) (Open Access) Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other co-morbidities. Drug-drug interactions associated with this polypharmacy are relatively new to the field of HCV pharmacotherapy. With the advent of the direct-acting antivirals telaprevir and boceprevir, which are both substrates and inhibitors of the cytochrome P450 (CYP) 3A iso-enzyme, knowledge and awareness of drug-drug interactions have become a cornerstone in the evaluation of patients starting and continuing HCV combination therapy. In our opinion, an overview of conducted dr…

medicine.medical_specialtyCombination therapyPharmacologyAntiviral AgentsDrug interactionsTelaprevirTelaprevirchemistry.chemical_compoundPharmacotherapyAnti-Infective AgentsBoceprevirOpiate Substitution TreatmentmedicineHumansHypnotics and SedativesHypoglycemic AgentsPharmacokineticsSummary of Product CharacteristicsIntensive care medicineAdverse effectPolypharmacyBoceprevirHepatologybusiness.industryHCV therapyCardiovascular AgentsHepatitis C ChronicAntidepressive AgentsBuprenorphinechemistryCardiovascular agentHepatitis C virus infectionDrug Therapy CombinationHydroxymethylglutaryl-CoA Reductase InhibitorsPoverty-related infectious diseases Infectious diseases and international health [N4i 3]businessImmunosuppressive AgentsMethadonemedicine.drug
researchProduct

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNI…

2020

International audience; Introduction - Patients treated for malignancy are considered at risk of severe COVID-19. This exceptional pandemic has affected countries on every level, particularly health systems which are experiencing saturation. Like many countries, France is currently greatly exposed, and a complete reorganization of hospitals is ongoing. We propose here adaptations of diagnostic procedures, therapies and care strategies for patients treated for digestive cancer during the COVID-19 epidemic. Methods - French societies of gastroenterology and gastrointestinal (GI) oncology carried out this study to answer two main questions that have arisen (i) how can we limit high-risk situat…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralDigestive cancerMEDLINEAntineoplastic AgentsFrench Clinical Practice Guidelines[SDV.CAN]Life Sciences [q-bio]/CancerComorbidityMalignancyBetacoronavirus03 medical and health sciences0302 clinical medicineHealth carePandemicDisease Transmission InfectiousHumansChemotherapyMedicineInfection controlIntensive care medicinePandemicsDigestive System Surgical ProceduresSocieties MedicalGastrointestinal NeoplasmsInfection ControlHepatologySARS-CoV-2business.industryGastroenterologyCOVID-19Evidence-based medicinemedicine.diseaseComorbidityPatient Care ManagementCOVID-19 infection3. Good health030220 oncology & carcinogenesisSurgery030211 gastroenterology & hepatologyFranceCoronavirus InfectionsbusinessDigestive and Liver Disease
researchProduct

COVID-19: Relationship and Impact on Breastfeeding-A Systematic Review.

2021

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that was declared a Public Health Emergency of International Concern by the World Health Organization (WHO). One major problem faced is whether breastfeeding by mothers infected with the virus is safe. The objective of this work is to study the impact that the SARS-CoV-2 virus can have on breastfeeding, and whether the virus or antibodies can be transmitted from mother to child through milk. We carried out a systematic review of studies focusing on the impact of SARS-CoV-2 on breastfeeding by mothers infected with the virus. The bibliographic search was done through Medline (Pubmed), MedlinePlus and Google Scholar. From 292 re…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)breastfeedingvirusesBreastfeedingMEDLINEbreastmilkReviewMedlinePlusPregnancyvaccineMedicineHumansTX341-641Pregnancy Complications Infectiousinternet.websiteinternetPregnancyNutrition and DieteticsMilk HumanNutrition. Foods and food supplybusiness.industrySARS-CoV-2Public healthfungiCOVID-19Infantmedicine.diseaseInfectious Disease Transmission Verticalimmune systemBreast FeedingInfectious disease (medical specialty)Family medicineFemalebusinessBreast feedingFood ScienceNutrients
researchProduct